Company Filing History:
2 out of 109 
2 out of 1,454 
1 out of 138 
Years Active: 2019-2024
Title: Yves Evrard: Innovator in Pharmaceutical Chemistry
Introduction
Yves Evrard is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on fused pentacyclic imidazole derivatives. With a total of 3 patents, Evrard's inventions are aimed at addressing various human ailments.
Latest Patents
Evrard's latest patents focus on a series of fused pentacyclic imidazole derivatives. These compounds serve as potent modulators of human TNFa activity, which is beneficial in the treatment and prevention of a wide range of human ailments. These include autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders. Specifically, his inventions concern 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and their analogs.
Career Highlights
Throughout his career, Yves Evrard has worked with prominent companies in the pharmaceutical industry, including UCB Biopharma and Sanofi. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Evrard has collaborated with several professionals in his field, including Teresa De Haro Garcia and Michael Deligny. These collaborations have further enhanced his research and development efforts.
Conclusion
Yves Evrard stands out as a significant figure in pharmaceutical innovation, with a focus on developing treatments for various human ailments through his patented inventions. His work continues to impact the field positively.